TRCT
PASG icon

Tower Research Capital (TRC)’s Passage Bio PASG Stock Holding History

Tower Research Capital (TRC)’s Portfolio PASG Stock Details PASG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.94K Buy
+502
New +$5.2K ﹤0.01% 4245
2025
Q4 		– Sell
-289
Closed -$2.32K – 5468
2025
Q3 		$2.32K Sell
289
-1,175
-80% -$8.18K ﹤0.01% 4649
2025
Q2 		$11.7K Buy
1,464
+1,148
+363% +$8.39K ﹤0.01% 3904
2025
Q1 		$2.23K Sell
316
-2,408
-88% -$26K ﹤0.01% 4574
2024
Q4 		$30.9K Buy
2,724
+2,472
+981% +$32.2K ﹤0.01% 2883
2024
Q3 		$3.52K Sell
252
-408
-62% -$6.5K ﹤0.01% 4829
2024
Q2 		$10.5K Buy
660
+658
+32,900% +$16.1K ﹤0.01% 4146
2024
Q1 		$46 Buy
+2
New +$48 ﹤0.01% 5713
2023
Q4 		– Sell
-686
Closed -$9.03K – 6105
2023
Q3 		$9.03K Buy
686
+557
+432% +$9.15K ﹤0.01% 4275
2023
Q2 		$2.42K Sell
129
-1,523
-92% -$30.1K ﹤0.01% 5202
2023
Q1 		$32K Sell
1,652
-528
-24% -$14.3K ﹤0.01% 2929
2022
Q4 		$60K Buy
2,180
+99
+5% +$2.5K ﹤0.01% 2207
2022
Q3 		$52K Buy
2,081
+985
+90% +$38.8K ﹤0.01% 3129
2022
Q2 		$51K Buy
1,096
+320
+41% +$14.9K ﹤0.01% 2863
2022
Q1 		$48K Buy
776
+696
+870% +$57.4K ﹤0.01% 2768
2021
Q4 		$10K Sell
80
-29
-27% -$4.74K ﹤0.01% 4594
2021
Q3 		$22K Sell
109
-198
-64% -$47.2K ﹤0.01% 3636
2021
Q2 		$81K Buy
307
+151
+97% +$46.7K ﹤0.01% 2595
2021
Q1 		$55K Buy
156
+112
+255% +$47.8K ﹤0.01% 3048
2020
Q4 		$23K Sell
44
-575
-93% -$230K ﹤0.01% 3778
2020
Q3 		$162K Buy
619
+580
+1,487% +$200K ﹤0.01% 2761
2020
Q2 		$21K Buy
39
+32
+457% +$14.4K ﹤0.01% 3655
2020
Q1 		$2K Buy
+7
New +$2.19K ﹤0.01% 2617

Other funds holding PASG

LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
YCM
Yiheng Capital Management San Francisco, California $231M AUM 29.07% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Tower Research Capital (TRC)'s PASG Position: Q1 2026 in Review

Tower Research Capital (TRC) opened a new position in Passage Bio (PASG) in Q1 2026: 502 shares worth $3.94K. The stake represents ﹤0.01% of the portfolio and ranks #4245 among its holdings. This is a return to the name: Tower Research Capital (TRC) previously reported a position in PASG as recently as Q3 2025.

Tower Research Capital (TRC) first reported a position in PASG in Q1 2020 and has held it in 23 quarters since. The position peaked at $162K in Q3 2020. 35 funds tracked by Wall St. Rank hold PASG as of Q1 2026.

  • Tower Research Capital (TRC) held 502 shares of Passage Bio worth $3.94K as of Q1 2026.
  • Passage Bio was a new Tower Research Capital (TRC) position in Q1 2026.
  • Passage Bio made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q1 2026, its #4245 holding.
  • Tower Research Capital (TRC) first reported a position in Passage Bio in Q1 2020 and has held it in 23 quarters since.
  • Tower Research Capital (TRC)'s Passage Bio position peaked at $162K in Q3 2020.
  • 35 funds tracked by Wall St. Rank held Passage Bio as of Q1 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2026, filed 15 May 2026.